COVID-19 vaccines for children younger than 12 years: are we ready?
- PMID: 34197765
- PMCID: PMC8238447
- DOI: 10.1016/S1473-3099(21)00384-4
COVID-19 vaccines for children younger than 12 years: are we ready?
Comment on
-
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial.Lancet Infect Dis. 2021 Dec;21(12):1645-1653. doi: 10.1016/S1473-3099(21)00319-4. Epub 2021 Jun 28. Lancet Infect Dis. 2021. PMID: 34197764 Free PMC article. Clinical Trial.
References
-
- Centers for Disease Control and Prevention COVID-19 vaccines for children and teens. 2021. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/adole... - PubMed
-
- Han B, Song Y, Li C, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021 doi: 10.1016/S1473-3099(21)00319-4. published online June 28. - DOI - PMC - PubMed
-
- American Academy of Pediatrics Children and COVID-19: state-level data report. 2021. https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infect...
-
- Kaushik A, Gupta S, Sood M, Sharma S, Verma S. A systematic review of multisystem inflammatory syndrome in children associated with SARS-CoV-2 infection. Pediatr Infect Dis J. 2020;39:e340–e346. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical